Buda Juice LLC

Buda Juice, Inc. announced its first quarter fiscal 2026 financial results, reporting a 17.7% increase in revenue to $3.5 million and a 37% rise in free cash flow.

Buda Juice, Inc. announced the full exercise of its IPO over-allotment option, raising total gross proceeds to approximately $23.0 million and signaling strong investor confidence in its UltraFresh juice platform.

Buda Juice, Inc. announced the pricing of its initial public offering of 2,666,667 shares at $7.50 per share, raising $20 million, and commenced trading on the NYSE American exchange.

Buda Juice, Inc. reports an 11.8% increase in net sales to $12.6 million for 2025, maintaining profitability despite higher produce costs and IPO-related expenses, as it transitions to a public company.

Buda Juice, a pioneer in the UltraFresh™ juice category, is launching its initial public offering to raise capital for national expansion and strengthen its cold-chain distribution network.

Buda Juice, Inc. is launching its initial public offering to raise up to $20 million, aiming to expand its 'UltraFreshTM' cold-crafted juice production and distribution across the U.S. while converting to a Delaware corporation.

Buda Juice, LLC is converting to a Delaware corporation and launching its initial public offering of 2,666,667 shares of common stock, aiming to expand its UltraFresh juice category nationally.

Buda Juice, a pioneer in the UltraFreshTM juice category, files for an IPO to raise up to $20 million, targeting NYSE listing and funding national expansion and a CEO stock redemption.

Buda Juice, Inc. is launching its initial public offering to raise capital for national expansion of its 'UltraFresh' juice platform, despite high customer concentration and a portion of proceeds going to CEO share redemption.

Buda Juice, Inc. is launching its initial public offering to fund ambitious geographic expansion and solidify its position in the rapidly growing UltraFresh™ juice category.

Director Bernard Lucien Nussbaumer has filed a Schedule 13G reporting beneficial ownership of 2,904,860 shares of Buda Juice, Inc. common stock.

Director and Executive Chairman Bryan Herr has filed a Schedule 13G reporting beneficial ownership of 18.79% of Buda Juice, Inc. common stock.

Horatio Lonsdale-Hands has filed a Schedule 13G reporting beneficial ownership of 2,249,417 shares of Buda Juice, Inc. common stock.

GROW Funds LLC has filed an amended Schedule 13G, revealing an 8.97% beneficial ownership stake in Buda Juice, Inc. common stock.

GROW Funds LLC has reported a 7.2% beneficial ownership stake in Buda Juice, Inc. common stock.